Introduction: Thyroid nodular goiter is clinically recognizable restricted structure changes of the thyroid gland. Numerous studies show the relationship between thyroid autoimmunity and differentiated thyroid cancer in patients with nodular thyroid goiter. One of the important clinical marker in defi ning thyroid autoimmunity are antibodies to thyroid peroxidase. Objective: The aim of this study was to analyze the relationship between anti peroxidase antibodies and thyroid malignancy in patients with nodular thyroid goiter.
Introduction:
Thyroid nodular goiter is clinically recognizable restricted structure changes of the thyroid gland. About 2-6% of the cases in this dIsease are discovered by palpation,19-35% are discovered by sensitive procedures like ultrasound and 8-65% by autopsy. Prevalence is linearly increasing for years by exposure to radiation and iodine defi ciency.It can occur endemically in areas with iodine defi ciency.Women fall sick more often than man (1).
Clinical forms of the dIsease include non-toxic nodular goiter,multinodular toxical goiter and toxical thyroid adenoma (Plummer`s desease).
Causes of the thyroid nodular dIsease can be benign (coloid nodules,Hashimoto`s thyroiditis,simple or hemorrhagic cysts,follicular adenoma,subacute thyroiditis) and malignant (primary follicular cell origin-papillary,follicular and anaplastic thyroid carcinoma,origin of C-cell thyroid-modular thyroid carcinoma,lymphoma and secondary metastatic carcinomas).
Diagnose of the dIsease is based on physical examination,laboratory testing, fi ne needle aspiration (FNA) and by visualization method (scintigraphy, ultrasound and ultrasound elastography,CT,MR and PET).
Fine needle aspiration (FNA) is crucial diagnostic procedure and fi rst line of nodular thyroid goiter diagnostic tests. Qualifi cation of diagnostic categories of thyroid FNA usually involves the following categories: `malignant` , `benign` , `unspecifi ed` , `unsuccessful`. The term refers to the indefi nite lesions which based on cytological appearance couldn`t be classifi ed with certainty in one of the groups benign or malignant,and these include follicular,Hurthle cell and suspicious fi ndings.Category was unsuccesfuly related to those samples which didn`t have enough material or the same material wasn`t adequate for diagnosis.
Therapy is usually surgical or radioiodine ablation, while recently in indicated cases for that is applying recombinant therapy with human thyrotropin,,percutaneous ethanol injection,laser thermal ablation and radiofrequency ablation.
Clinical signifi cance of thyroid nodular diseas beside esthetic changes,such as neck thickening,local compressive syndromes and thyroid dysfunction is possibility of developing malignancy in 5% cases. Annual incidence of thyroid carcinoma is 1-2 on 100.000 people,which makes 90% malignancy of the entire endocrine system,1%of all malignancies in humans and 0,5% of mortality due to malignancy. (1,2).
Numerous studies show the relationship between thyroid autoimmunity and differentiated thyroid cancer in patients with nodular thyroid goiter.
One of the important clinical marker in defi ning thyroid autoimmunity are antibodies to thyroid peroxidase.
Objective
The aim of this study was to analyze the relationship between anti peroxidase antibodies and thyroid malignancy in patients with nodular thyroid goiter.
Material and methods
The study was conducted at the Clinic for Endocrinology, Diabetes and Meta- The patients were ambulatory examined,medical history is taken and laboratory tests were performed (biochemistry,blood test and hormonal status) ECG and ultrasound were performed and some patients had scintigraphy of the thyroid gland.After that (FNA) fi ne needle aspiration is performed ,obtained preparations analysed in the Institute of Pathology in Clinical centre of Serbia in Belgrade.
Cytological examination of samples FNA are qualifi ed by diagnostic category seed of thyroid FNA like:benign,malignant,unspecifi ed and unsuccessful.
We analyzed the relationship between fi ndings of cytopathological diagnostic categories and serum concentrations of anti peroxidase antibodies.
The data were statistically processed using the computer program SPSS 12.0 software package.
Results
Of total 248 patients, 148 patients (59.7%) had anti-TPO antibody values in a reference limits (30 IU / ml), and 40.3% elevated anti-TPO antibodies (over 30 IU / ml). The graphical results are shown in graph 1. 
Anti TPO At
The value of antibodies is examined in regard to diagnostic categories. Anti TPO antibodies values are divided in two groups and the fi rst (to 30IU/ml) which includes normal values of antibodies and second (over 30IU/ml) which includes increased values of antibodies Table 1 shows the value of anti TPO antibodies by diagnostic categories. 
Discussion
Hashimoto`s thyroiditis and Graves' disease are two most common forms of thyroid autoimmunities,which characterize lymphocytic infi ltration and auto-reactivity against thyroid autoantigenes (3).
Thyroid peroxidase is the major enzyme involved in thyroid hormonal geneticks,primarily identifi ed like microsomal antigen.It`s considered that these antibodies on this enzyme are the major cause of the thyroid gland infl ammation.These antibodies are found in serum of patients with autoimmune diseases of thyroid gland. They are present in nearly all patients with Hashimoto`s thyroiditis,in two-thirds of patients with postpartum thyroiditis and almost 75% of patients with Graves` hyperthyroidism.Anti peroxidase antibodies are produced by lymphocytes that in the state of infl ammation infi ltrate the gland,to a lesser extent lymphocytes that have origin of regional lymph glands and bone marrow.Antibodies damage the cells of the thyroid gland by induction antibody dependent cell mediated citotoxicity.
Hashimoto`s thyroiditis leads to development of hypothyroidism and to serum concentration and increase of thyrotropin hormone (TSH),while on the contrary of that Graves` desease,also with autoimmune nature,anderlying the pathogenesis we have the growth of TSH concentration through TSH receptors stimulation.From referred it could be assumed that the connection between humoral thyroid autoimmunity and thyroid malignity is made through TSH receptors.
The results of our study show that from 248 patients,148 of patients (59,7%) had anti TPO antibody values in the normal limits (to 30IU/ml),but 40,3% had the increased values of anti TPO antibodies (over 30IU/ml).In the group of patients with increased values of anti TPO antibodies even 7% (7/100) of patients is with malignant cytological fi ndings,and in group of patients with anti TPO antibody values in normal limits is only 1.4% (2/148) with malignant cytological fi ndings.
Based on the results it may be note signifi cantly higher proportion of patients with malignant cytological fi ndings and with increased values of anti peroxidase antibodies. Numerous studies that have been done examined the connection between autoimmune thyroid disease and differentiated thyroid carcinoma.
Even if there isn`t an agreement of all,target analysis of 10 studies by Singh and collaborators has shown that with patients who have Hashimoto`s thyroiditis have even 2.77 times higher risc for appearance of thyroid malignancy compared with the control group. Boelaert and collaborators in study done in 2006 have shown signifi cantly higher frequency of cancer in patients with the present anti peroxidase antibodies in comparison with patients where were present antibodies.
Contrary to already specifi ed,the study of Fiore and collaborators shows that between the patients with anti peroxidase positive and negative antibodies there is no difference in frequency of thyroid malignancy. The study Rebuffat with collaborators has shown that anti TPO antibodies achieve cell-mediated cytotoxicity and antiproliferative activity in papillary thyroid carcinoma cells (4).
Based on numerous studies it`s accepted that focal chronic lymphocytic thyroiditis (whether it`s nonspecifi c or Hashimoto`s) leads to the development of malignancy,while the connection between diffuse chronic thyroiditis and thyroid malignancy still remains unclarifi ed.
Conclusion
Defi ning the relationship between thyroid autoimmune disease and differentiated thyroid cancer, providing new insights in the fi eld of immunotherapy of thyroid carcinoma. Enlightening the molecular mechanisms link autoimmune thyroid disease and thyroid cancer development in patients with thyroid nodule help fi nd new therapeutic strategies against thyroid cancer.
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